Nearly a week after the sudden passing of wrestling legend Hulk Hogan, medical officials have confirmed that the 71-year-old ...

Enoumena Therapeutics Inc. and AOP Health today announced an exclusive commercialization agreement to expand Canadian ...

Global Fish-Oil Based Drugs Market size is expected to be worth around US$ 9.0 Billion by 2034 from US$ 4.9 Billion in 2024.

Eli Lilly's noncovalent BTK inhibitor Jaypirca has been cleared by the FDA in its first frontline indication for chronic ...

Did YouTube convince a man to make movies for clicks that ruined his life?

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved an additional ...

FDA expands pirtobrutinib into first-line CLL/SLL for adults without 17p deletion, delivering major PFS gains versus ...

FDA authorized frontline pirtobrutinib for previously untreated CLL/SLL without known 17p deletion, expanding use beyond its established relapsed/refractory setting after covalent BTK inhibition.

Klara Klein, MD, PhD, of the University of North Carolina School of Medicine in Chapel Hill, reported the ACHIEVE-4 trial results at the annual meeting of the European Association for the Study of ...

Your child takes life insurance, and after his death the insurer denies the claim on the basis that your son hid a ...

Nature MedicinePulsed field ablation (PFA) has rapidly changed the landscape of atrial fibrillation ablation.The procedure is ...